Baxdela 450 mg Oral Tablet
RxNorm 1927682
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1927682 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Baxdela 450 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Baxdela 450 mg (as delafloxacin meglumine 649 mg) Oral Tablet
(Atom ID: 9197721)
PSNPrescribable
Prescribable Name (PSN):
Baxdela 450 mg Oral Tablet
(Atom ID: 9197723)
SYPrescribable
Synonym (SY):
Baxdela 450 mg Oral Tablet
(Atom ID: 9197718)
SBDPrescribable
Semantic Branded Drug (SBD):
Delafloxacin 450 mg Oral Tablet [Baxdela]
(Atom ID: 9197717)
Patient Education
Delafloxacin
Delafloxacin is used to treat skin infections and certain types of pneumonia (an infection of the lungs) caused by bacteria in adults. Delafloxacin is in a class of antibiotics called fluoroquinolones. It works by killing the bacteria that cause infections. Antibiotics such as delafloxacin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
[Learn More]
* Please review the disclaimer below.